Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
CPAC Stock Summary
Top 10 Correlated ETFs
CPAC
In the News
Cementos Pacasmayo S.A.A. (CPAC) Q4 2023 Earnings Call Transcript
Cementos Pacasmayo S.A.A. (CPAC) Q4 2023 Earnings Call Transcript
71 Ben Graham January Value Stocks, 56 Jazzed Buys
Large Cap Value is a value ranking strategy that looks at the price of a stock relative to measurements of intrinsic firm value. The Ben Graham Formula strategy selects ultra-stable stocks based on a screen in Graham's book, "The Intelligent Investor." 56 out of 71 All-Star-Value Dividend stocks offer annual dividends exceeding their price per share.
Are Investors Undervaluing Cementos Pacasmayo (CPAC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Cementos Pacasmayo (CPAC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Cementos Pacasmayo (CPAC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
66 Ben Graham October Value Stocks: 56 Outrageous Buys
“Value ranking, looks at the price of a stock relative to. intrinsic firm value. Graham Value Stocks match the criteria . Benjamin Graham followed. “—YCharts Value Screener. 66 August Value large caps and Graham formula-derived results reflect established value-stock detection-criteria. Of those, 56 met the dogcatcher-outrageous-ideal of dividends from $1K invested exceeding single-share-stock-prices. Representing nine-of-eleven Morningstar Sectors, all 56 ideal value-picks pay regular-dividends. Broker-target-top-ten net-gains ranged 33.15%-84.12%, topped by PDM & SQM, as-of 9/22/23.
70 Ben Graham August Value Stocks, 59 Absurd Buys
“Value ranking, looks at the price of a stock relative to intrinsic firm value. Graham Value Stocks match the criteria Benjamin Graham followed. “—YCharts Value Screener. 70 August Value large caps and Graham formula-derived results reflect established value stock detection criteria. Of those, 59 met our absurd ideal of dividends from $1K invested exceeding single share stock prices. Representing nine-of-eleven Morningstar Sectors, all 59 ideal value picks pay regular dividends. Broker-target-top-ten net gains ranged 27.38%-55.94%, topped by PDM & TRMD, as of 8/1/23.
Cementos Pacasmayo: Strong Q2 2023 Results Thanks To Resilient Cement Demand In Peru
The company's Q2 2023 revenues decreased by 12.1% and EBITDA went down by just 6.6%. Cement demand in Peru has been unusually strong over the past few months in light of ongoing political protests and weak economic growth. The government expects GDP growth in July to be high, and I'm optimistic that cement demand in the country will remain robust over the coming months.
Cementos Pacasmayo S.A.A. (CPAC) Q1 2023 Earnings Call Transcript
Cementos Pacasmayo S.A.A. (NYSE:CPAC ) Q1 2023 Results Conference Call April 27, 2023 11:00 AM ET Company Participants Claudia Bustamante - Investor Relations Humberto Nadal - Chief Executive Officer Manuel Ferreyros - Chief Financial Officer Operator Good morning, everyone, and welcome to the Cementos Pacasmayo First Quarter 2023 Earnings Conference Call [Operator Instructions].
Cementos Pacasmayo: Early 2023 Could Be Challenging (Rating Downgrade)
The company finished 2022 on a strong note with Q4 sales and gross profit rising by 1.7% and 1.1% despite nationwide protests in Peru in December. However, cement consumption in Peru slumped by over 15% over the first two months of 2023 as protests raged and is now barely above pre-pandemic levels.
CPAC Financial details
CPAC Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 16.27 | 15.14 | 22.77 | 25.58 | 4.56 | |
Net income per share | 1.54 | 0.68 | 1.8 | 2.14 | 0.39 | |
Operating cash flow per share | 2.4 | 3.87 | 2 | 1.35 | 0.96 | |
Free cash flow per share | 1.43 | 3.26 | 0.89 | -0.81 | 0.29 | |
Cash per share | 0.8 | 3.61 | 3.21 | 2.04 | 0.21 | |
Book value per share | 16.6 | 15.97 | 14.05 | 14.45 | 2.78 | |
Tangible book value per share | 16.09 | 15.43 | 13.41 | 13.71 | 2.77 | |
Share holders equity per share | 16.6 | 15.97 | 14.05 | 14.45 | 2.78 | |
Interest debt per share | 13.6 | 14.96 | 1.11 | 1.2 | 3.93 | |
Market cap | 2.62B | 2.31B | 2.11B | 1.62B | 8.17B | |
Enterprise value | 3.65B | 3.21B | 1.84B | 1.54B | 9.66B | |
P/E ratio | 19.81 | 39.93 | 13.78 | 9.17 | 48.35 | |
Price to sales ratio | 1.88 | 1.78 | 1.09 | 0.77 | 4.19 | |
POCF ratio | 12.75 | 6.98 | 12.37 | 14.51 | 19.8 | |
PFCF ratio | 21.42 | 8.29 | 27.76 | -24.33 | 66.38 | |
P/B Ratio | 1.84 | 1.69 | 1.76 | 1.36 | 6.86 | |
PTB ratio | 1.84 | 1.69 | 1.76 | 1.36 | 6.86 | |
EV to sales | 2.62 | 2.48 | 0.95 | 0.73 | 4.95 | |
Enterprise value over EBITDA | 9.17 | 10.38 | 5.46 | 4.12 | 18.17 | |
EV to operating cash flow | 17.79 | 9.7 | 10.8 | 13.81 | 23.42 | |
EV to free cash flow | 29.89 | 11.52 | 24.24 | -23.16 | 78.5 | |
Earnings yield | 0.05 | 0.03 | 0.07 | 0.11 | 0.02 | |
Free cash flow yield | 0.05 | 0.12 | 0.04 | -0.04 | 0.02 | |
Debt to equity | 0.78 | 0.88 | 0 | 0 | 1.33 | |
Debt to assets | 0.38 | 0.4 | 0 | 0 | 0.49 | |
Net debt to EBITDA | 2.6 | 2.91 | -0.79 | -0.21 | 2.81 | |
Current ratio | 2.12 | 3.31 | 1.4 | 1.25 | 1.44 | |
Interest coverage | 4.36 | 2.49 | 3.58 | 3.74 | 3.79 | |
Income quality | 1.06 | 3.86 | 0.76 | 0.43 | 2.44 | |
Dividend Yield | 0.05 | 0.06 | 0.16 | 0.11 | 0.02 | |
Payout ratio | 0.91 | 2.48 | 2.2 | 1.02 | 1.04 | |
Sales general and administrative to revenue | 0.1 | 0.1 | 0.09 | 0.12 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.02 | 0.02 | 0.02 | 0 | |
Capex to operating cash flow | -0.4 | -0.16 | -0.55 | -1.6 | -0.7 | |
Capex to revenue | -0.06 | -0.04 | -0.05 | -0.08 | -0.15 | |
Capex to depreciation | -0.64 | -0.38 | -0.7 | -1.29 | -2.02 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 24 | 15.59 | 23.86 | 26.37 | 4.97 | |
ROIC | 0.07 | 0.05 | 0.18 | 0.2 | 0.1 | |
Return on tangible assets | 0.05 | 0.02 | 0.05 | 0.05 | 0.05 | |
Graham Net | -12.75 | -12.22 | -15.9 | -17.31 | -3.43 | |
Working capital | 395.65M | 612.67M | 287.23M | 235.31M | 302.86M | |
Tangible asset value | 1.38B | 1.32B | 1.14B | 1.13B | 1.19B | |
Net current asset value | -761.58M | -770.99M | -996.58M | -930.57M | -1.04B | |
Invested capital | 0.78 | 0.88 | 0 | 0 | 1.33 | |
Average receivables | 109.96M | 102.3M | 93.39M | 102.1M | 102.83M | |
Average payables | 77.23M | 84.32M | 155.65M | 256.05M | 195.94M | |
Average inventory | 471.89M | 489.81M | 532.9M | 745.08M | 838.02M | |
Days sales outstanding | 31.59 | 23.67 | 19.35 | 17.51 | 19.5 | |
Days payables outstanding | 34.21 | 33.19 | 60.26 | 70.96 | 30.64 | |
Days of inventory on hand | 209.14 | 182.53 | 160.26 | 220.68 | 225.82 | |
Receivables turnover | 11.55 | 15.42 | 18.86 | 20.85 | 18.72 | |
Payables turnover | 10.67 | 11 | 6.06 | 5.14 | 11.91 | |
Inventory turnover | 1.75 | 2 | 2.28 | 1.65 | 1.62 | |
ROE | 0.09 | 0.04 | 0.13 | 0.15 | 0.14 | |
Capex per share | -0.97 | -0.61 | -1.11 | -2.16 | -0.68 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 6.17 | 5.61 | 5.16 | 6.03 | 7.13 | |
Net income per share | 0.45 | 0.51 | 0.51 | 0.54 | 0.5 | |
Operating cash flow per share | 0.58 | -0.69 | 1.25 | 2.89 | 1.62 | |
Free cash flow per share | -0.27 | -1.62 | 0.36 | 1.74 | 1.13 | |
Cash per share | 1.95 | 0.53 | 0.88 | 2.17 | 1.26 | |
Book value per share | 13.82 | 14.48 | 14.99 | 15.53 | 16.59 | |
Tangible book value per share | 13.11 | 13.75 | 14.24 | 14.77 | 16.53 | |
Share holders equity per share | 13.82 | 14.48 | 14.99 | 15.53 | 16.59 | |
Interest debt per share | 0.32 | 0.34 | 0.37 | 0.4 | 22.43 | |
Market cap | 1.7B | 452.08M | 1.58B | 1.67B | 1.37B | |
Enterprise value | 1.62B | 410.61M | 1.52B | 1.5B | 2.86B | |
P/E ratio | 10.9 | 2.6 | 9.08 | 9.07 | 9.54 | |
Price to sales ratio | 3.18 | 0.94 | 3.57 | 3.24 | 2.68 | |
POCF ratio | 33.74 | -7.65 | 14.72 | 6.75 | 11.8 | |
PFCF ratio | -72.27 | -3.26 | 51.38 | 11.2 | 16.85 | |
P/B Ratio | 1.42 | 0.36 | 1.23 | 1.26 | 1.15 | |
PTB ratio | 1.42 | 0.36 | 1.23 | 1.26 | 1.15 | |
EV to sales | 3.03 | 0.86 | 3.44 | 2.91 | 5.59 | |
Enterprise value over EBITDA | 17.7 | 3.36 | 13.39 | 11.48 | 17.75 | |
EV to operating cash flow | 32.2 | -6.95 | 14.18 | 6.07 | 24.66 | |
EV to free cash flow | -68.97 | -2.96 | 49.49 | 10.06 | 35.23 | |
Earnings yield | 0.02 | 0.1 | 0.03 | 0.03 | 0.03 | |
Free cash flow yield | -0.01 | -0.31 | 0.02 | 0.09 | 0.06 | |
Debt to equity | 0 | 0 | 0.01 | 0.01 | 1.33 | |
Debt to assets | 0 | 0 | 0 | 0 | 0.49 | |
Net debt to EBITDA | -0.85 | -0.34 | -0.51 | -1.3 | 9.26 | |
Current ratio | 1.25 | 1.9 | 1.76 | 1.63 | 1.44 | |
Interest coverage | 3.66 | 3.37 | 3.26 | 3.4 | 4.48 | |
Income quality | 0.79 | -0.93 | 1.79 | 3.69 | 3.23 | |
Dividend Yield | 0.11 | 0 | 0 | 0 | 0.13 | |
Payout ratio | 4.6 | 0.01 | 0 | 0 | 4.86 | |
Sales general and administrative to revenue | 0.12 | 0.12 | 0.13 | 0.11 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0 | |
Capex to operating cash flow | -1.47 | 1.35 | -0.71 | -0.4 | -0.3 | |
Capex to revenue | -0.14 | -0.17 | -0.17 | -0.19 | -0.07 | |
Capex to depreciation | -2.11 | -2.35 | -2.25 | -2.63 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 11.83 | 12.87 | 13.08 | 13.72 | 13.66 | |
ROIC | 0.04 | 0.05 | 0.04 | 0.05 | 0.03 | |
Return on tangible assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham Net | -16.55 | -17.01 | -17 | -16.44 | -20.47 | |
Working capital | 235.31M | 528.12M | 488.04M | 434.21M | 302.86M | |
Tangible asset value | 1.13B | 1.18B | 1.22B | 1.26B | 1.19B | |
Net current asset value | -930.57M | -927.92M | -933.44M | -948.99M | -1.04B | |
Invested capital | 0 | 0 | 0.01 | 0.01 | 1.33 | |
Average receivables | 107.75M | 101.61M | 96.9M | 94.08M | 100.13M | |
Average payables | 214.77M | 252.15M | 227.35M | 256.25M | 192.43M | |
Average inventory | 848.91M | 907.6M | 930.08M | 873.8M | 804.38M | |
Days sales outstanding | 17.11 | 19.08 | 18.75 | 16.74 | 18.33 | |
Days payables outstanding | 69.07 | 61.92 | 73.05 | 73.03 | 31.19 | |
Days of inventory on hand | 214.81 | 262.12 | 289.13 | 215.16 | 229.86 | |
Receivables turnover | 5.26 | 4.72 | 4.8 | 5.38 | 4.91 | |
Payables turnover | 1.3 | 1.45 | 1.23 | 1.23 | 2.89 | |
Inventory turnover | 0.42 | 0.34 | 0.31 | 0.42 | 0.39 | |
ROE | 0.03 | 0.04 | 0.03 | 0.03 | 0.03 | |
Capex per share | -0.85 | -0.93 | -0.89 | -1.15 | -0.48 |
CPAC Frequently Asked Questions
What is Cementos Pacasmayo S.A.A. stock symbol ?
Cementos Pacasmayo S.A.A. is a PE stock and trading under the symbol CPAC
What is Cementos Pacasmayo S.A.A. stock quote today ?
Cementos Pacasmayo S.A.A. stock price is $5.99 today.
Is Cementos Pacasmayo S.A.A. stock public?
Yes, Cementos Pacasmayo S.A.A. is a publicly traded company.